Reasons Into Hantavirus-Related Biotech: 3 Cautions
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
Biotech
Biotech insights await. This page curates 5 articles on Tempus, Moderna, Praxis, ImmunityBio and market moves to help you evaluate stocks and sharpen your portfolio strategy.
88 articles
Verrica (VRCA) 2026 Earnings Outlook and Strategic Plan
Analysts watch Verrica's 2026 earnings for clues on VP-102 sales, cash runway, and pipeline progress. This guide brea...
This Million Shows Growing Confidence in 10x Genomics
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Halozyme (Halo) 2026 Earnings: A Practical Investor Guide
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...
Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Biotech Stocks Rally Hantavirus: Is the Move Overdone?
A limited hantavirus outbreak has sent waves through biotech stocks, mirroring post-pandemic behavior. This article b...
Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Overlooked Stocks Soar 2026: Hidden Winners Ahead in 2026
Smart investors look beyond the loud headlines. This guide explains how overlooked stocks soar 2026 by spotting catal...
This Millionaire-Maker Biotech Stock: Worth Buying Now?
What could turn a biotech bet into a life-changing gain? This article breaks down how to spot this millionaire-maker ...
Vericel (VCEL) 2026 Earnings Outlook and Strategy
Vericel faces a pivotal 2026 earnings season. This guide breaks down the drivers behind the numbers, what to watch in...
Crinetics (CRNX) 2026 Earnings Outlook and Analysis
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
RMTI 2026 Earnings Transcript: What Investors Need
A clear guide to reading RMTI's Q1 2026 earnings call, what the numbers mean, and how to spot the catalysts that can ...